[1]
2026. Evaluating the Antitumor Activity of Nintedanib by Solid Lipid Nanoparticle Drug Delivery System: In vitro and In vivo.
Asian Journal of Pharmaceutics (AJP)
. 19, 04 (Feb. 2026). DOI:
https://doi.org/10.22377/ajp.v19i04.7190
.